Dihydroergotamine Mesylate Nasal

Product NDC: 69097-740
11-digit product format: 690970740
Labeler code: 69097
Product ID: 69097-740_c6908afb-ab07-4962-bb1c-5e671e1d2c54
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dihydroergotamine Mesylate Nasal
Dosage form: SPRAY, METERED
Route: NASAL
Labeler: Cipla USA Inc.
Application: ANDA212907
Marketing category: ANDA
Marketing start: 2020-12-11
Marketing end: 0000-00-00
Substance: DIHYDROERGOTAMINE MESYLATE
Active strength: 4 mg/mL
Pharmacologic classes: Ergotamine Derivative [EPC], Ergotamines [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69097-740-31	2024-01-31	C162847	48780-1	1030e365-44e0-111a-e063-dadaa90a10e2	c4ad46ac-7c5a-4224-9cd0-4e7a3bc8e5d4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69097-740-31	ML - Milliliter	69097-740	2f17c7dc-0611-43b6-89f7-907f601d48ee	1	2021-01-08

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69097-740-31	69097074031	1 VIAL in 1 KIT (69097-740-31) > 1 mL in 1 VIAL	1 vial	2020-12-11	0000-00-00	No	No	Current